Concert Pharmaceuticals has developed AVP-786 (CTP-786 or deuterated dextromethorphan) and reached a milestone under Avanir Pharmaceuticals collaboration. Avanir completed first of a two-stage pharmacokinetic study of AVP-786 in healthy ...
Tags: Concert Pharmaceuticals, Avanir Pharmaceuticals collaboration, AVP-786